Management

Per Andersson

Chief Executive Officer

CEO at Xspray Pharma since 2006
Born 1967

Per Andersson has been the CEO of Xspray Pharma AB since 2006. Per Andersson has extensive experience from the medical industry, especially within patent work and strategies. Previous positions include Science Director at Gyros AB and Scientist at GE Healthcare

Education: Ph.D. in Analytical Chemistry, Stockholm university

Mission: Other current activities: Chariman of the board of Robotic Lawn Care Sweden AB and Deputy of Journeyman Stockholm AB

Holdings: 115,403 shares and 154,857 warrants

Independent in relation to the larger shareholders but not in relation to the company

Andreas Konar

Business Development

Business development at Xspray since 2010
Born 1949

Andreas Konar has 4 decades of experience from the pharmaceutical industry in R&D, clinical research, project management and business development. He has been VP R&D at Dumex and AL Pharma, responsible for the Drug Delivery Business Unit at LifeCycle Pharma, business development at Recordati and section manager at Astra Draco

Education: Associate Professor in Organic Chemistry, University of Lund, Sweden
Ph.D. in Organic Chemistry, University of Lund, Sweden
M.Sc. in Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden

Mission: Member of the Board of Ground Zero Pharmaceuticals, Irvine, CA, USA

Holdings in the Company: 73 555 shares and 19 091 warrants

Independent in relation to major shareholders but not in relation to the Company

Charlotta Liljebris

VP Research and Development

VP R & D at Xspray Pharma since 2018
Born 1964

Charlotta Liljebris has 25 years of experience from the pharmaceutical industry. She has been responsible for the project portfolio and business development at Orexo, VP R&D at Aprea with focus on oncology and worked in several leading positions within project management at Biovitrum.

Education: Ph.D. in Medicinal Chemistry, Uppsala University, Sweden
M.Sc. in Chemistry, Uppsala University, Sweden

Mission: Other current assignments: Member of the Board of Sprint Bioscience

Other Board assignments (the rexent 5 years): Member of the Board of Recipharm OT Chemistry and Connect Uppsala

Holdings in the Company: 1200 shares and 23 437 warrants

Independent in relation to major shareholders but not in relation to the Company.

Kerstin Hasselgren

Chief Financial Officer

CFO at Xspray Pharma since 2019
Born 1961

Kerstin Hasselgren has broad experience from working in large public international companies as VP Corporate Business Control at SSAB, CFO at Alstom Transport Nordic, VP Finance Global Operations at AstraZeneca and VP Finance Global R&D at AstraZeneca

Education: M.Sc. Business Administration, Stockholm School of Economics

Mission: Other current assignments: None

Other Board assignments (the recent 5 years): None

Holdings in the Company: 4500 shares

Independent in relation to major shareholders but not in relation to the Company